To startup founder and Stanford Medical graduate Jesse Karmazin, blood is the next big government-approved drug. Karmazin recently launched Ambrosia Medical - a startup that fills the veins of ...
As Business Insider previously reported, Ambrosia's founder, Jesse Karmazin, has said the transfusions are safe and reliable, despite little to no hard scientific evidence to demonstrate either ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results